Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Minimizing spending doesn’t have to be a challenge. Explore effortless ways to keep your expenses low while enjoying life.
22,570 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
eBay rejected GameStop's unsolicited $56 billion takeover offer, labeling it neither credible attractive. The decisio...
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Explore how Pixelworks PXLW 2026 earnings shape a small-cap tech stock. This guide breaks down the key metrics, poten...
Fresh federal data for early 2026 confirm that graduates with a bachelor’s degree face the lowest unemployment rates,...
A quiet SEC filing reveals a larger stake in Par Pacific. Explore what forest avenue capital adds means for investors...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
Rigetti Computing stock surged as government funding boosted optimism for quantum tech. Learn what happened, what it ...
Three diversified commodity ETFs have surged more than 32% over the past year as inflation pressures persist. Here’s ...
Starting a portfolio in AI is daunting but doable. This guide lays out practical trades you could make today, with co...
Two major price cuts from Chinese AI labs are changing the economics of frontier AI. For crypto traders and funds, ch...